NCT01611051: A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy |
|
|
| Completed | 3 | 330 | RoW | Drug: Pegylated rhG-CSF: 100µg/kg, Pegylated rhG-CSF: 6mg, rhG-CSF 5ug/kg/day | Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer, Neutropenia, Febrile Neutropenia | 01/13 | | | |
